Allianz SE: AHR position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Allianz SE on AHR, newest first. How the timeline and the estimate are built.
Allianz SE held 238,713 AHR shares at 2026-06-30 per its 13F-HR/A filed 2026-09-02.
the latest 13F is the newest step
- period ended2026-06-3013F/A 238,713 sharesChange vs previous 13F -103,695 shares
0.01% of the 13F portfolio, value $12,448,883.
13F-HR/A 0001193125-26-379716 filed by Allianz Asset Management GmbH
Accepted , ingested - period ended2026-03-3113F 342,408 sharesChange vs previous 13F -20,607 shares
0.02% of the 13F portfolio, value $16,147,961.
13F-HR 0001193125-26-216255 filed by Allianz Asset Management GmbH
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 363,015 sharesChange vs previous 13F +101,827 shares
0.02% of the 13F portfolio, value $17,083,486.
13F-HR 0001193125-26-046254 filed by Allianz Asset Management GmbH
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 261,188 sharesChange vs previous 13F +170,709 shares
0.01% of the 13F portfolio, value $10,972,508.
13F-HR 0001193125-25-264422 filed by Allianz Asset Management GmbH
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 90,479 sharesChange vs previous 13F +1,793 shares
<0.01% of the 13F portfolio, value $3,324,198.
13F-HR 0000950123-25-006674 filed by Allianz Asset Management GmbH
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 88,686 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $2,687,186.
13F-HR 0000950123-25-004032 filed by Allianz Asset Management GmbH
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).